Candid Health Lands $120M in Series D Funding
2026-07-23
Tweet
SAN FRANCISCO, CA, Candid Health, the autonomous RCM platform, announced that it has raised $120M in Series D funding led by Sixth Street Growth.
Candid Health, the autonomous RCM platform, announced that it has raised $120M in Series D funding led by Sixth Street Growth, the dedicated growth investing platform of Sixth Street, with participation from Oak HC/FT, 8VC, and Y Combinator. This funding marks a 3X increase in valuation over Candid's Series C fundraise in February 2025, which was led by Oak HC/FT.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors
